publicli
avail
rtpcr
assay
adapt
evalu
open
mode
neumodx
system
qiagen
assay
show
compar
analyt
clinic
perform
refer
assay
fast
turnaround
time
minut
randomaccess
workflow
system
make
assay
well
suit
urgent
clinic
sampl
background
ongo
pandem
present
uniqu
challeng
diagnost
laboratori
around
world
autom
workflow
molecular
diagnost
instrument
cope
larg
number
test
order
clinician
well
provid
fasttrack
rapid
test
highli
urgent
case
studi
evalu
ldt
neumodx
system
fulli
autom
devic
perform
extract
realtim
pcr
method
publicli
avail
rtpcr
assay
adapt
autom
system
analyt
perform
evalu
use
invitro
transcrib
rna
clinic
perform
compar
coba
refer
assay
within
lab
result
neumodxsarbecoldt
display
good
analyt
perform
lod
cpml
fals
posit
evalu
reactiv
total
patient
sampl
test
sarbecoldt
refer
assay
posit
neg
agreement
respect
invalidr
neumodxsarbecoldt
show
analyt
clinic
perform
compar
refer
assay
due
randomaccess
workflow
concept
rapid
result
minut
devic
well
suit
provid
fasttrack
diagnost
urgent
clinic
sampl
hospit
set
introduct
earli
januari
first
identifi
like
caus
agent
cluster
case
viral
pneumonia
citi
wuhan
china
novel
viru
situat
sarbecoviru
subgenu
along
genet
distinct
rel
origin
sarscoronaviru
saw
rapid
spread
worldwid
eventu
prompt
declar
global
health
emerg
end
januari
outbreak
scenario
present
uniqu
challeng
diagnost
laboratori
particularli
case
respiratori
virus
clinic
symptom
larg
indistinguish
common
respiratori
pathogen
eg
influenza
polymeras
chain
reaction
pcr
assay
necessari
confirm
rule
novel
viru
varieti
suitabl
assay
made
avail
earli
outbreak
notabl
corman
et
al
cdc
swiftli
adopt
mani
lab
europ
around
world
howev
overal
test
capac
remain
limit
other
previous
demonstr
autom
molecular
diagnost
enabl
easi
scale
test
capac
substanti
cut
back
handson
time
assay
present
studi
use
fulli
autom
randomaccess
platform
molecular
diagnost
handl
everyth
extract
amplif
signal
detect
report
result
rna
target
timetoresult
approxim
minut
given
optim
condit
avail
open
mode
allow
rapid
implement
lab
develop
test
ldt
aim
studi
adapt
evalu
previous
publish
pcr
assay
corman
et
al
accord
instruct
issu
manufactur
primerprob
mix
prepar
mix
load
ldtstrip
well
well
reaction
eg
primer
nm
probe
per
reaction
complet
run
protocol
see
testsummari
display
tabl
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
step
denatur
sec
detect
step
anneal
sec
detect
tabl
neumodxsoftwar
runprotocol
summari
display
set
pcr
protocol
clinic
specimen
use
studi
oropharyng
nasopharyng
swab
eswab
collect
kit
copan
itali
prior
analysi
roch
coba
pcr
medium
guanidin
hydrochlorid
trishcl
buffer
ad
sampl
order
inactiv
potenti
pathogen
within
facilit
handl
sampl
briefli
vortex
load
instrument
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
taqman
base
rtpcrassay
novel
viru
avail
onlin
mere
day
initi
sequenc
publish
howev
assay
implement
rel
swiftli
local
diagnost
laboratori
relianc
manual
pcr
setup
set
narrow
limit
overal
capac
studi
reusken
et
al
report
coronaviru
end
januari
almost
countri
european
union
capac
test
per
week
less
vast
major
similar
issu
report
earli
china
test
could
perform
suspect
case
due
limit
capac
recent
studi
demonstr
previous
publish
taqman
base
rtpcr
assay
endors
ecdc
adapt
run
autom
batchbas
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
signal
detect
without
requir
human
interact
provid
randomaccess
capabl
turnaround
time
minut
rna
target
studi
adapt
rtpcr
assay
corman
et
al
use
neumodx
autom
system
analyt
clinic
perform
compar
refer
assay
show
lod
approxim
copiesml
posit
neg
agreement
respect
rel
high
inhibit
rate
suggest
sampl
prepar
procedur
optim
neumodxbas
sarbecoldt
repres
valuabl
complement
routin
test
offer
abil
run
individu
highprior
sampl
time
report
result
within
two
hour
necessari
studi
adapt
publicli
avail
screen
assay
use
open
channel
neumodx
system
qiagen
assay
demonstr
compar
analyt
clinic
perform
establish
ldt
current
use
diagnost
due
randomaccess
capabl
short
turnaround
time
minut
system
well
suit
autom
mediumthroughput
routin
test
addit
highthroughput
system
allow
fasttrack
highli
urgent
clinic
sampl
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
